Valérie Perron

417 total citations
11 papers, 315 citations indexed

About

Valérie Perron is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Valérie Perron has authored 11 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Valérie Perron's work include Bioactive Compounds and Antitumor Agents (2 papers), HIV Research and Treatment (2 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). Valérie Perron is often cited by papers focused on Bioactive Compounds and Antitumor Agents (2 papers), HIV Research and Treatment (2 papers) and Synthesis and Characterization of Heterocyclic Compounds (2 papers). Valérie Perron collaborates with scholars based in Canada and France. Valérie Perron's co-authors include Gervais Bérubé, Éric Asselin, Boulos Zacharie, Christopher Penney, Brent R. Stranix, Sophie Parent, René C.‐Gaudreault, Caroline Descôteaux, Isabelle Mathieu and Sanat K. Mandal and has published in prestigious journals such as Synthesis, Bioorganic & Medicinal Chemistry Letters and Steroids.

In The Last Decade

Valérie Perron

11 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Valérie Perron Canada 8 242 104 90 41 17 11 315
Fabio Agnelli United States 10 181 0.7× 229 2.2× 42 0.5× 17 0.4× 8 0.5× 10 391
Jean‐Marie Ferland Canada 12 311 1.3× 237 2.3× 78 0.9× 12 0.3× 52 3.1× 24 496
Chien‐Shu Chen Taiwan 11 194 0.8× 184 1.8× 35 0.4× 13 0.3× 22 1.3× 23 361
Florian Taft Germany 13 139 0.6× 273 2.6× 13 0.1× 23 0.6× 17 1.0× 20 421
Christophe Mellon Canada 11 186 0.8× 149 1.4× 46 0.5× 11 0.3× 18 1.1× 20 372
Kübra Açıkalın Coşkun Türkiye 8 224 0.9× 153 1.5× 65 0.7× 6 0.1× 12 0.7× 22 426
Madhusudhan Gowravaram United States 11 169 0.7× 216 2.1× 70 0.8× 22 0.5× 29 1.7× 11 363
Tomohisa Moriguchi Japan 11 125 0.5× 271 2.6× 16 0.2× 13 0.3× 26 1.5× 42 385
Nunzio Sciammetta United States 10 161 0.7× 246 2.4× 21 0.2× 9 0.2× 13 0.8× 18 390
John F. Mehlmann United States 7 144 0.6× 68 0.7× 39 0.4× 26 0.6× 4 0.2× 11 221

Countries citing papers authored by Valérie Perron

Since Specialization
Citations

This map shows the geographic impact of Valérie Perron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valérie Perron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valérie Perron more than expected).

Fields of papers citing papers by Valérie Perron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valérie Perron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valérie Perron. The network helps show where Valérie Perron may publish in the future.

Co-authorship network of co-authors of Valérie Perron

This figure shows the co-authorship network connecting the top 25 collaborators of Valérie Perron. A scholar is included among the top collaborators of Valérie Perron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valérie Perron. Valérie Perron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Zacharie, Boulos, Jean‐Simon Duceppe, Lyne Gagnon, et al.. (2018). Design and Synthesis of New 1,3,5‐Trisubstituted Triazines for the Treatment of Cancer and Inflammation. ChemistryOpen. 7(9). 737–749. 10 indexed citations
3.
Perron, Valérie, et al.. (2009). Synthesis and antimicrobial activity of 2-fluorophenyl-4,6-disubstituted [1,3,5]triazines. Bioorganic & Medicinal Chemistry Letters. 20(3). 945–949. 57 indexed citations
4.
Perron, Valérie, et al.. (2009). ChemInform Abstract: A Method for the Selective Protection of Aromatic Amines in the Presence of Aliphatic Amines.. ChemInform. 40(22). 2 indexed citations
5.
Zacharie, Boulos, et al.. (2008). A Method for the Selective Protection of Aromatic Amines in the Presence of Aliphatic Amines. Synthesis. 2009(2). 283–289. 6 indexed citations
6.
Stranix, Brent R., et al.. (2006). Lysine sulfonamides as novel HIV-protease inhibitors: Nε-Acyl aromatic α-amino acids. Bioorganic & Medicinal Chemistry Letters. 16(13). 3459–3462. 72 indexed citations
8.
9.
Stranix, Brent R., et al.. (2004). Lysine sulfonamides as novel HIV-protease inhibitors: Nε-disubstituted ureas. Bioorganic & Medicinal Chemistry Letters. 14(15). 3971–3974. 14 indexed citations
10.
Perron, Valérie, et al.. (2003). A facile synthesis of C2-symmetric 17β-estradiol dimers. Bioorganic & Medicinal Chemistry Letters. 13(3). 557–560. 16 indexed citations
11.
Descôteaux, Caroline, Isabelle Mathieu, Valérie Perron, et al.. (2003). Synthesis of 17β-estradiol platinum(II) complexes: biological evaluation on breast cancer cell lines. Bioorganic & Medicinal Chemistry Letters. 13(22). 3927–3931. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026